269. Bad Medicine, Part 2: (Drug) Trials and Tribulations
How do so many ineffective and even dangerous drugs make it to market? One reason is that clinical trials are often run on "dream patients" who aren't representative of a larger population. On the other hand, sometimes the only thing worse than being excluded from a drug trial is being included.
Episode 269 of the Freakonomics Radio podcast, hosted by Freakonomics Radio + Stitcher, titled "269. Bad Medicine, Part 2: (Drug) Trials and Tribulations" was published on December 8, 2016 and runs 45 minutes.
December 8, 2016 ·45m · Freakonomics Radio
Summary
How do so many ineffective and even dangerous drugs make it to market? One reason is that clinical trials are often run on "dream patients" who aren't representative of a larger population. On the other hand, sometimes the only thing worse than being excluded from a drug trial is being included.
Episode Description
How do so many ineffective and even dangerous drugs make it to market? One reason is that clinical trials are often run on "dream patients" who aren't representative of a larger population. On the other hand, sometimes the only thing worse than being excluded from a drug trial is being included.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.